Home/Filings/4/0001437749-25-033905
4//SEC Filing

Davis Scott G. 4

Accession 0001437749-25-033905

CIK 0001549084other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 5:48 PM ET

Size

6.0 KB

Accession

0001437749-25-033905

Insider Transaction Report

Form 4
Period: 2025-11-05
Davis Scott G.
DirectorCEO
Transactions
  • Award

    Common Stock

    2025-11-05+80,000102,092 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    373
Footnotes (3)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
  • [F2]The RSU grant was approved by the Board of Directors in a meeting held on November 5, 2025, under the Company's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). Each RSU Award was fully vested at grant.
  • [F3]On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Issuer

EKSO BIONICS HOLDINGS, INC.

CIK 0001549084

Entity typeother

Related Parties

1
  • filerCIK 0001908860

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 5:48 PM ET
Size
6.0 KB